Natalijia Novak
9PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 04, 2024
Monkeypox 2024 outbreak: Fifty essential questions and answers.Beatriz Cabanillas, Giuseppe Murdaca, Amir Guemari
|Apr 27, 2023
Differences in allergen-specific basophil activation and T cell proliferation in atopic dermatitis patients with comorbid allergic rhinoconjunctivitis treated with a monoclonal anti-IL-4Rα antibody or allergen-specific immunotherapy.Anne-Sophie Layritz, Jorge Galicia-Carreón, Said Benfadal
|Jan 01, 2023
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak.Beatriz Cabanillas, Giuseppe Murdaca, Amir Guemari
|Oct 13, 2022
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long-term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis.Natalija Novak, Margitta Worm, Petra Staubach
|Apr 23, 2022
JAK1/2 inhibitor but not IL-4 receptor alpha antibody suppresses allergen-mediated activation of human basophils in vitro.Wenming Peng, Said Benfadal, Chunfeng Yu
|Jun 15, 2021
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".Beatriz Cabanillas, Cezmi A Akdis, Natalija Novak
Pageof 2
Frequent Collaborators
5 joint publications
Cezmi A Akdis
4 joint publications
Beatriz Cabanillas
2 joint publications
Ruben Fernández-Santamaria
2 joint publications
Joana Vitte
2 joint publications
Riccardo Castagnoli
2 joint publications
Emel Aksoy
2 joint publications
Giuseppe Murdaca
2 joint publications
Amir Guemari
2 joint publications
Maria Jose Torres
2 joint publications
Ahmet Kursat Azkur
